CDKN2A and neoplasm: While CDKN2A is a tumor suppressor, its robust protein expression is a recognized biomarker of oncogene-induced cellular senescence or a dysfunctional cell cycle checkpoint in many cancers, a state that could be exacerbated by the diabetic metabolic environment.